Losartan Potassium Tablet
Product Images NDC 50090-5626

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-5626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 01)

Chemical structure of Losartan Potassium, showing its molecular formula with various rings and side chains, including potassium ion (K+).*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 02)

A line graph comparing the percentage of patients with a primary endpoint over time in months for Atenolol and Losartan. The x-axis represents study months (0 to 66), and the y-axis shows the percentage of patients (0 to 16%). Atenolol data is shown with a dotted line, and Losartan data is displayed as a solid line. The graph notes an adjusted risk reduction of 13% with p=0.021.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 03)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a study period of up to 66 months for two drugs: Atenolol (dotted line) and Losartan (solid line). The graph shows a lower percentage of stroke events for Losartan compared to Atenolol. The graph includes an annotation of an adjusted risk reduction of 25% with a p-value of 0.001.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 04)

A comparison chart showing hazard ratios with 95% confidence intervals for primary composite and stroke (fatal/non-fatal) events between Losartan and Atenolol. It includes patient demographics such as age, gender, race, ISH, diabetes, and history of cardiovascular disease, with event rates and hazard ratios indicating which treatment is favored.*

FDA Label Image

Image (A27c3ddf 3129 4f3e Bc0e 37381cc1a167 05)

A line graph comparing the percentage of patients with an event over 48 months for Losartan versus placebo. The solid line represents Losartan and the dashed line represents placebo. The graph shows a risk reduction of 16.1% with Losartan, with a p-value of 0.022, indicating statistical significance.*

FDA Label Image

Label Image (Lbl500905626)

Losartan Potassium 25 mg oral tablets label from A-S Medication Solutions. The label states each film-coated tablet contains Losartan Potassium 25 mg and instructs storage at 77 degrees F with protection from light. It shows a package count of 30 tablets and includes dosage and lot information along with the product NDC 50090-5626-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.